{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:43:21Z","timestamp":1783115001234,"version":"3.54.6"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Spanish Ministerio de Econom\u00eda y Competitividad (MINECO)","doi-asserted-by":"publisher","award":["SAF2011-22802"],"award-info":[{"award-number":["SAF2011-22802"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Spanish Ministerio de Econom\u00eda y Competitividad (MINECO)","doi-asserted-by":"publisher","award":["BFU2015-70067-REDC"],"award-info":[{"award-number":["BFU2015-70067-REDC"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Spanish Ministerio de Econom\u00eda y Competitividad (MINECO)","doi-asserted-by":"publisher","award":["SAF2015-66275-C2-R"],"award-info":[{"award-number":["SAF2015-66275-C2-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PROMETEO\/2014\/011"],"award-info":[{"award-number":["PROMETEO\/2014\/011"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ejmech.2017.10.083","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T01:19:18Z","timestamp":1509585558000},"page":"157-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Amino acid and peptide prodrugs of diphenylpropanones positive allosteric modulators of \u03b17 nicotinic receptors with analgesic activity"],"prefix":"10.1016","volume":"143","author":[{"given":"Beatriz","family":"Balsera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Mulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"de la Torre-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Gonz\u00e1lez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Plata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieve","family":"Naesens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2741-1427","authenticated-orcid":false,"given":"Asia","family":"Fern\u00e1ndez-Carvajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ferrer-Montiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Criado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5095-5882","authenticated-orcid":false,"given":"Mar\u00eda Jes\u00fas","family":"P\u00e9rez de Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8833-4328","authenticated-orcid":false,"given":"Rosario","family":"Gonz\u00e1lez-Mu\u00f1iz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.10.083_bib1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s40263-015-0260-0","article-title":"The therapeutic potential of \u03b17 nicotinic acetylcholine receptor (\u03b17 nAChR) agonists for the treatment of the cognitive deficits associated with schizophrenia","volume":"29","author":"Beinat","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejmech.2017.10.083_bib2","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.neuropharm.2011.01.044","article-title":"Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits","volume":"62","author":"D'Souza","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2017.10.083_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.mp.4001035","article-title":"Nicotinic acetylcholine receptors as targets for antidepressants","volume":"7","author":"Shytle","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejmech.2017.10.083_bib4","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bcp.2011.06.039","article-title":"Research update: alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease","volume":"82","author":"Parri","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.10.083_bib5","first-page":"37","article-title":"a7 Nicotinic receptor agonists: potential therapeutic drugs for treatment of cognitive impairments in schizophrenia and Alzheimer's disease","volume":"4","author":"Toyohara","year":"2010","journal-title":"Open Med. Chem. J."},{"key":"10.1016\/j.ejmech.2017.10.083_bib6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.pharmthera.2007.05.007","article-title":"The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation?","volume":"115","author":"Gwilt","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2017.10.083_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/art.24177","article-title":"Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice","volume":"60","author":"van Maanen","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejmech.2017.10.083_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuroscience.2016.12.029","article-title":"Spinal activation of alpha7-nicotinic acetylcholine receptor attenuates posttraumatic stress disorder-related chronic pain via suppression of glial activation","volume":"344","author":"Sun","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2017.10.083_bib9","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1111\/bph.13528","article-title":"The \u03b17 nicotinic receptor dual allosteric agonist and positive allosteric modulator GAT107 reverses nociception in mouse models of inflammatory and neuropathic pain","volume":"173","author":"Bagdas","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.10.083_bib10","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.bcp.2013.08.001","article-title":"Neuronal nicotinic receptors as analgesic targets: it's a winding road","volume":"86","author":"Umana","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.10.083_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.neulet.2013.05.073","article-title":"Choline, an alpha7 nicotinic acetylcholine receptor agonist, alleviates hyperalgesia in a rat osteoarthritis model","volume":"548","author":"Lee","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2017.10.083_bib12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.39411","article-title":"Involvement of mast cells in \u03b17 nicotinic receptor agonist exacerbation of Freund's complete adjuvant-induced monoarthritis in mice","volume":"68","author":"Lopes","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ejmech.2017.10.083_bib13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/jpet.112.197871","article-title":"The antinociceptive effects of nicotinic receptors \u03b17-positive allosteric modulators in murine acute and tonic pain models","volume":"344","author":"Freitas","year":"2013","journal-title":"J.\u00a0Pharm. Exp. Ther."},{"key":"10.1016\/j.ejmech.2017.10.083_bib14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1476-5381.2012.02226.x","article-title":"In\u00a0vivo pharmacological interactions between a type II positive allosteric modulator of \u03b17 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model","volume":"169","author":"Freitas","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.10.083_bib15","first-page":"1162","article-title":"Systemic administration of an Alpha-7 nicotinic acetylcholine agonist reverses neuropathic pain in male Sprague Dawley rats","volume":"13","author":"Loram","year":"2012","journal-title":"J.\u00a0Pain"},{"key":"10.1016\/j.ejmech.2017.10.083_bib16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuropharm.2012.08.022","article-title":"Effects of alpha 7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models","volume":"65","author":"Freitas","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2017.10.083_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.toxicon.2014.11.222","article-title":"Nicotinic acetylcholine receptor \u03b17 subunit is involved in the cobratoxin-induced antinociception in an animal model of neuropathic pain","volume":"93","author":"Gong","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.ejmech.2017.10.083_bib18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bcp.2011.05.001","article-title":"Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations","volume":"82","author":"Williams","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.10.083_bib19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrd2927","article-title":"Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system","volume":"8","author":"Taly","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2017.10.083_bib20","doi-asserted-by":"crossref","first-page":"7943","DOI":"10.1021\/jm2007672","article-title":"Discovery and development of \u03b17 nicotinic acetylcholine receptor modulators","volume":"54","author":"Mazurov","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.083_bib21","doi-asserted-by":"crossref","first-page":"10277","DOI":"10.1021\/jm3013568","article-title":"N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): a medicinal chemistry effort toward an \u03b17 nicotinic acetylcholine receptor agonist preclinical candidate","volume":"55","author":"Zanaletti","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.083_bib22","doi-asserted-by":"crossref","first-page":"8943","DOI":"10.1021\/jm401267t","volume":"56","author":"Thakur","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.083_bib23","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ejmech.2014.09.039","article-title":"Chalcones as positive allosteric modulators of \u03b17 nicotinic acetylcholine receptors: a new target for a privileged structure","volume":"86","author":"Balsera","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.083_bib24","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4155\/fmc-2015-0001","article-title":"1,3-diphenylpropan-1-ones as allosteric modulators of \u03b17 nACh receptors with analgesic and antioxidant properties","volume":"8","author":"Criado","year":"2016","journal-title":"Fut. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.083_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1734-1140(13)70959-9","article-title":"Prodrugs: a challenge for the drug development","volume":"65","author":"Zawilska","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2017.10.083_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/molecules21010042","article-title":"The prodrug approach: a successful tool for improving drug solubility","volume":"21","author":"Hartmann Jornada","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2017.10.083_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1042\/bst0140383","article-title":"Peptide derivatives as prodrugs","volume":"14","author":"Thomas","year":"1986","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejmech.2017.10.083_bib28","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1128\/AAC.39.12.2759","article-title":"Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans","volume":"39","author":"Soul-Lawton","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2017.10.083_bib29","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.bmcl.2005.01.065","article-title":"Cyclization-activated prodrugs. Synthesis, reactivity and toxicity of dipeptide esters of paracetamol","volume":"15","author":"Santos","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.083_bib30","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/j.ejmech.2008.08.009","article-title":"Structure-activity relationships for dipeptide prodrugs of acyclovir: implications for prodrug design","volume":"44","author":"Santos","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.083_bib31","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/cmdc.201100504","article-title":"Dipeptidyl peptidase IV (DPPIV\/CD26)-Based prodrugs of hydroxy-containing drugs","volume":"7","author":"Diez-Torrubia","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2017.10.083_bib32","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejmech.2013.10.001","article-title":"Novel water-soluble prodrugs of acyclovir cleavable by the dipeptidyl-peptidase IV (DPP IV\/CD26) enzyme","volume":"70","author":"Diez-Torrubia","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.083_bib33","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/psc.2672","article-title":"Cell penetration: scope and limitations by the application of cell-penetrating peptides","volume":"20","author":"Reissmann","year":"2014","journal-title":"J.\u00a0Pept. Sci."},{"key":"10.1016\/j.ejmech.2017.10.083_bib34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0040-4039(00)94371-5","article-title":"PyBOP\u00ae: a new peptide coupling reagent devoid of toxic by-product","volume":"31","author":"Coste","year":"1990","journal-title":"Tet. Lett."},{"key":"10.1016\/j.ejmech.2017.10.083_bib35","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1021\/ol061147j","article-title":"Pd\/C-Catalyzed chemoselective hydrogenation in the presence of diphenylsulfide","volume":"8","author":"Mori","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2017.10.083_bib36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1476-5381.2012.02003.x","article-title":"The alpha7 nicotinic ACh receptor agonist compound B and positive allosteric modulator PNU-120596 both alleviate inflammatory hyperalgesia and cytokine release in the rat","volume":"167","author":"Munro","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.10.083_bib37","first-page":"735","article-title":"Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in\u00a0vivo analgesic and anti-inflammatory activity","volume":"7","author":"Garc\u00eda-Mart\u00ednez","year":"2006","journal-title":"J.\u00a0Pain"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417308851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417308851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T21:33:07Z","timestamp":1540416787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417308851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":37,"alternative-id":["S0223523417308851"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.10.083","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amino acid and peptide prodrugs of diphenylpropanones positive allosteric modulators of \u03b17 nicotinic receptors with analgesic activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.10.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}